GlassScriptPhysician profile
Aaron J Sugalski
NPI 1699957845
$9,083.85
in general payments reported to CMS, 2019-2025
17 companies · $8,486 in 2025
The $8,486 reported for 2025 was more than what 84% of Pediatric Hematology-Oncology providers received nationally (typical 2025 total: $207).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $272 · 2022: $76.75 · 2023: $57.94 · 2024: $191 · 2025: $8,486.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $7,140 · Food and Beverage: $1,261 · Travel and Lodging: $304 · Education: $30.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $7,140.00 |
| Food and Beverage | $1,260.67 |
| Travel and Lodging | $303.97 |
| Education | $30.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Hema Biologics, LLC | $7,801.16 | 2025 | Iwilfin |
| Uswm, LLC | $348.83 | 2024-2025 | Iwilfin |
| Alexion Pharmaceuticals, INC. | $146.85 | 2019-2024 | Ultomiris |
| Btg International INC. | $125.00 | 2025 | Voraxaze |
| Jazz Pharmaceuticals INC. | $111.89 | 2023-2025 | Rylaze |
| Pharming Healthcare, INC. | $106.50 | 2025 | |
| Servier Pharmaceuticals LLC | $102.77 | 2019-2025 | |
| Pfizer INC. | $80.32 | 2019 | |
| Rhythm Pharmaceuticals, INC. | $63.89 | 2022 | |
| Sanofi Pasteur INC. | $49.78 | 2025 | |
| Syndax Pharmaceuticals, INC. | $27.71 | 2025 | |
| Day One Biopharmaceuticals | $27.41 | 2024 | Ojemda |
| Photocure INC | $23.88 | 2019 | |
| Kyowa Kirin, INC. | $18.40 | 2025 | |
| Karl Storz Endoscopy-America | $17.28 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $16.62 | 2019 | |
| Grifols USA, LLC | $15.56 | 2025 | Xembify |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Aaron Sugalski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.